Anivamersen Uses, Dosage, Side Effects and more
Anivamersen is under investigation in clinical trial NCT01848106 (A Study to Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI).
| Trade Name | Anivamersen |
| Generic | Anivamersen |
| Anivamersen Other Names | Anivamersen, Rna, (cm-gm-cm-gm-gm-um-am-um-am-gm-um-cm-cm-am-cm) |
| Type | |
| Formula | C157H208N56O103P14 |
| Weight | Average: 4961.313 Monoisotopic: 4958.908624754 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
